台股 » 個股 » 昇陽 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

昇陽

(3266)
可現股當沖
  • 股價
    20.95
  • 漲跌
    ▲0.70
  • 漲幅
    +3.46%
  • 成交量
    1,935
  • 產業
    上市 營建類股
  • 34人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
昇陽 (3266)籌碼相關-統一-屏東 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-屏東 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/26320.20320.5020.9506160.00%
2024/04/09319.5000.0019.7035130.58%
2024/03/1200.00118.4018.40-1751-0.13%
2024/03/08320.1500.0020.3537030.43%
2024/03/05120.9000.0021.5016820.15%
2024/02/20619.903619.9519.95-30824-3.64%
2024/02/1900.002220.4320.25-22820-2.68%
2024/02/1500.00419.0519.00-4789-0.51%
2024/02/051018.3100.0018.20107871.27%
2024/02/024518.5700.0018.45457905.69%
2024/01/12118.9000.0018.8017340.14%
2023/12/1100.00121.1521.15-1420-0.24%
2023/03/1300.00212.3512.30-299-2.00%
2023/03/09212.9500.0012.652882.25%
2022/08/2600.00112.2012.20-1207-0.48%
2022/05/0600.00713.7013.65-7708-0.99%
2022/05/03214.2500.0013.9526990.29%
2022/04/26214.1500.0013.7526730.30%
2022/04/1900.00114.6514.70-1613-0.16%
2022/04/1800.00314.9314.85-3590-0.51%
2022/04/1500.00416.3816.45-4541-0.74%
2022/04/14216.9000.0016.5524990.40%
2022/04/13816.5600.0016.5084561.75%
2022/04/12215.756415.8416.65-62341-18.17%
2022/04/1112115.136014.8315.156118333.17% 大買/
2020/09/01113.8500.0013.6511200.83%
2020/05/2800.00113.6013.60-1329-0.30%
2020/05/2700.00514.1014.00-5326-1.53%
2020/05/2200.00213.2013.25-2317-0.63%
2020/05/15314.1200.0014.1532671.12%
2020/03/1700.004012.1012.20-40129-30.92%
2020/01/16115.1500.0015.0011030.96%
2019/10/23515.0500.0015.0054171.20%
2019/10/1700.00116.3016.30-1412-0.24%
2019/10/08116.0000.0015.4013690.27%
2019/09/1000.00213.6013.55-2319-0.63%
2019/08/29214.5000.0014.3522900.69%
2019/08/28113.8000.0013.9512720.37%
2019/08/23114.0000.0014.5012430.41%
2019/08/20813.582813.7913.75-20198-10.08%
2019/08/192013.5000.0013.502013614.64%
2018/12/0700.00211.2011.30-289-2.24%
2018/06/25212.4000.0012.0021651.21%
2018/06/224512.954512.8012.3001350.00%
昇陽半攻先進製程、先進封裝 明年營運勝今年Anue鉅亨-2023/12/24
昇陽半生技布局報捷 多合一液態蛋白檢測平台完成臨床前測試Anue鉅亨-2023/12/21
昇陽 相關文章